OLMA
Olema Pharmaceuticals Inc
7.90$
-4.0%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 96.3% | 96.2% | 95.6% | 95.1% | 94.7% | 97.2% | 96.8% | 96.3% | 94.9% | 96.6% | 96.7% | 96.6% | |
| 40.1% | 24.7% | 12.8% | 6.6% | 15.6% | 30.9% | 12.4% | 13.7% | 10.0% | 9.1% | 9.9% | 10.0% | |
| 94.6% | 94.5% | 94.4% | 93.9% | 93.3% | 96.3% | 95.9% | 94.7% | 93.3% | 94.8% | 95.2% | 94.8% | |
| 0.3% | 0.2% | 0.3% | 0.3% | 0.3% | 0.5% | 0.5% | 0.7% | 0.8% | 0.8% | 0.6% | – | |
| 1.4% | – | 0.9% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | 0.2% | 0.2% | 0.2% | – | – | – | – | |
| 6.0% | 8.3% | 10.4% | 10.8% | 13.6% | 9.3% | 6.4% | 9.6% | 12.8% | 10.3% | 9.5% | 11.5% | |
| 5.5% | 7.8% | 9.9% | 10.4% | 13.3% | 9.3% | 6.4% | 8.7% | 11.8% | 9.7% | 8.9% | 10.9% | |
| 0.3% | 0.4% | 0.4% | 0.4% | 0.5% | 0.3% | 0.3% | 0.3% | 0.3% | 0.2% | 0.2% | 0.1% | |
| 0.8% | 1.0% | 2.9% | 1.7% | 1.2% | 1.0% | 0.0% | 0.2% | 1.0% | 1.7% | 0.7% | 0.3% | |
| – | – | – | – | – | – | – | 0.8% | 0.9% | 0.6% | 0.6% | 0.6% | |
| 94.0% | 91.7% | 89.6% | 89.2% | 86.4% | 90.7% | 93.6% | 90.4% | 87.2% | 89.7% | 90.5% | 88.5% | |
| -95.2% | -110.4% | -127.6% | -144.2% | -174.5% | -96.5% | -113.6% | -133.3% | -156.5% | -112.0% | -122.6% | -146.7% | |
| 15.4% | 19.8% | 21.1% | 22.1% | 24.9% | 13.0% | 20.9% | 22.4% | 24.3% | 17.1% | 19.4% | 21.5% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.